Abstract
陈静锋,秦迁,吴卓青,闫肃,宋晓琴,丁素英.谷丙转氨酶轨迹与新发代谢相关脂肪性肝病相关性的队列研究[J].Chinese journal of Epidemiology,2022,43(2):234-240
谷丙转氨酶轨迹与新发代谢相关脂肪性肝病相关性的队列研究
A cohort study on the correlation between alanine aminotransferase trajectories and new-onset metabolic fatty liver disease
Received:August 09, 2021  
DOI:10.3760/cma.j.cn112338-20210809-00621
KeyWord: 谷丙转氨酶轨迹  代谢相关脂肪性肝病  队列研究  危险因素
English Key Word: Alanine aminotransferase trajectories  Metabolic fatty liver disease  Cohort study  Risk factor
FundProject:国家自然科学基金(72101236);河南省高等学校重点科研项目(21A320035);河南省医学科技攻关计划联合共建项目(LHGJ20200279,LHGJ20200311);河南省青年人才托举工程项目(2021HYTP052)
Author NameAffiliationE-mail
Chen Jingfeng Health Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
School of Public Health, Zhengzhou University, Zhengzhou 450000, China 
 
Qin Qian Health Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China  
Wu Zhuoqing Institute of Systems Engineering, Dalian University of Technology, Dalian 116024, China  
Yan Su Health Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
School of Public Health, Zhengzhou University, Zhengzhou 450000, China 
 
Song Xiaoqin Health Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China  
Ding Suying Health Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
School of Public Health, Zhengzhou University, Zhengzhou 450000, China 
fccdingsy@zzu.edu.cn 
Hits: 2173
Download times: 623
Abstract:
      目的 探讨谷丙转氨酶(ALT)轨迹与新发代谢相关脂肪性肝病(MAFLD)的相关性,为MAFLD的防治提供科学依据。方法 以河南体检人群队列研究中符合入选标准的3 553例观察对象组成研究队列,依据观察对象2017-2019年健康体检的ALT水平,采用R LCTMtools程序确定3个不同的ALT轨迹组,分别为低稳定组、中稳定组、高稳定组,随访各组人群2020年健康体检时MAFLD的发病情况,用乘积极限法计算各组累积发病率,用Cox比例风险回归模型分析不同ALT轨迹与新发MAFLD的相关性。结果 MAFLD的发病率随着ALT轨迹的升高而不断增加,低稳定组、中稳定组、高稳定组分别为6.93%、15.42%、19.05%,差异有统计学意义(P<0.001)。Cox比例风险回归模型调整性别、腰围、血压、BMI、血糖、血脂等多种混杂因素后,ALT中稳定组、高稳定组MAFLD发病风险仍为ALT低稳定组的1.422倍(95%CI:1.115~1.813)与1.483倍(95%CI:1.040~2.114)(P<0.05)。结论 发生MAFLD的风险随着长期正常范围内ALT水平的升高而增加,应对长期持续正常高值的MAFLD及时干预,延缓MAFLD疾病的进展,以实现早期预防MAFLD的目的。
English Abstract:
      Objective To explore the correlation between alanine aminotransferase (ALT) trajectories and new-onset metabolic fatty liver disease (MAFLD) to provide a scientific basis for the prevention and treatment of MAFLD. Methods The study cohort was composed of 3 553 subjects who met the inclusion criteria in the cohort study of the Henan physical examination population. According to the ALT levels of the subjects' physical examination from 2017-2019, three different ALT trajectory groups were determined by R LCTMtools, namely low-stable group, medium-stable group, and high-stable group. The incidence of MAFLD during physical examination in 2020 was followed up, the cumulative incidence rate in each group was calculated by product-limit method, and Cox proportional hazards regression model analyzed the correlation between different ALT trajectories and new-onset MAFLD. Results The incidence rate of MAFLD parallelly increased with the increase of ALT locus, which was 6.93%, 15.42%, and 19.05%, respectively, and the difference was statistically significant (P<0.001). After adjusting for multiple confounding factors, such as gender, waist circumference, blood pressure, BMI, fasting blood sugar, and blood lipid by Cox proportional hazards regression model, the risks of MAFLD in ALT medium-stable and the high-stable group were still 1.422 times (95%CI:1.115-1.813) and 1.483 times (95%CI:1.040-2.114) of low-stable ALT group (P<0.05). Conclusions The risk of MAFLD parallelly increases with the increase of ALT level in the normal long-term range. it is necessary to carry out the intervention for MAFLD with long-term average high value to avoid the progress of MAFLD disease to achieve the early prevention on MAFLD.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close